| pubmed-article:6239050 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C1167395 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C0567416 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C0027697 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C0002335 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C0003313 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C0036830 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C1527144 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C0051348 | lld:lifeskim |
| pubmed-article:6239050 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:6239050 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6239050 | pubmed:dateCreated | 1984-12-26 | lld:pubmed |
| pubmed-article:6239050 | pubmed:abstractText | The effect of prostaglandin E1 alpha-cyclodextrin host molecule (PGE1 . CD) was estimated by using a model of immune complex glomerulonephritis induced in rats by i.v. injection of 1 mg of rabbit serum albumin every other day. PGE1 . CD was given subcutaneously for 10 days after nephritis was definitely induced and resulted in a rapid restoration of various biochemical parameters, especially in plasma. The continuous s.c. administration of PGE1 . CD (300 micrograms/rat/day) with a mini osmotic pump provoked a therapeutic effect similar to that obtained with twice daily s.c. administration of PGE1 . CD (300 micrograms/rat X 2/day). Both PGE1 . CD groups revealed less glomerular damage and fewer locations of immune complexes in glomeruli as demonstrated by light and immunofluorescence microscopy. The beneficial effect of PGE1 . CD may be associated with reduced immune complex deposits in glomeruli. The present studies suggest that PGE1 . CD may enhance the clearance of immune complex deposits from the glomeruli rather than inhibiting the formation of immune complex in the circulation. | lld:pubmed |
| pubmed-article:6239050 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6239050 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6239050 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6239050 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6239050 | pubmed:issn | 0021-5198 | lld:pubmed |
| pubmed-article:6239050 | pubmed:author | pubmed-author:SuzukiYY | lld:pubmed |
| pubmed-article:6239050 | pubmed:author | pubmed-author:IkutaKK | lld:pubmed |
| pubmed-article:6239050 | pubmed:author | pubmed-author:AokiSS | lld:pubmed |
| pubmed-article:6239050 | pubmed:author | pubmed-author:NagamatsuTT | lld:pubmed |
| pubmed-article:6239050 | pubmed:author | pubmed-author:SaitohNN | lld:pubmed |
| pubmed-article:6239050 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6239050 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:6239050 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6239050 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6239050 | pubmed:pagination | 407-14 | lld:pubmed |
| pubmed-article:6239050 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:meshHeading | pubmed-meshheading:6239050-... | lld:pubmed |
| pubmed-article:6239050 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6239050 | pubmed:articleTitle | Studies on experimental immune complex nephritis (3). Therapeutic effect of prostaglandin E1 alpha-cyclodextrin host molecule (PGE1 . CD) on serum sickness nephritis in rats. | lld:pubmed |
| pubmed-article:6239050 | pubmed:publicationType | Journal Article | lld:pubmed |
